Related Experiment Video
Updated: Nov 22, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice
Louise van der Weyden1, Jos Jonkers2, David J Adams1
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom.
Abstract:
CRISPR/Cas9 systems have revolutionised the field of gene editing, allowing for precise modifications to be generated in vivo to mimic the genetic events found in human cancer cells. These systems may be used to generate germline or somatic loss-of-function of events, and also chromosomal rearrangements, either constitutively or in a spatiotemporally controlled manner. Forward genetic screens have also been performed using CRISPR/Cas9 systems to identify new driver genes and approaches using catalytically inactive Cas9 fused to base editors have enabled genome editing with single-base precision. Here we discuss the many 'flavours' of the CRISPR/Cas9 system and give examples of their use for the generation of clinically-relevant mouse models of cancer.
Insights
CRISPR/Cas9 gene editing tools precisely alter DNA in vivo, enabling the creation of accurate cancer models. These versatile systems facilitate genetic screens and base editing for advancing cancer research.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- CRISPR/Cas9 systems have transformed gene editing capabilities.
- Precise in vivo genetic modifications can now mimic human cancer events.
Purpose of the Study:
- To review CRISPR/Cas9 system variations and their applications.
- To highlight the generation of clinically relevant cancer mouse models using CRISPR/Cas9.
Main Methods:
- Utilizing CRISPR/Cas9 for germline/somatic loss-of-function and chromosomal rearrangements.
- Employing CRISPR/Cas9 for forward genetic screens to identify driver genes.
- Leveraging base editors fused to catalytically inactive Cas9 for single-base precision editing.
Main Results:
- CRISPR/Cas9 enables constitutive or spatiotemporally controlled genetic modifications.
- CRISPR/Cas9 facilitates the identification of novel cancer driver genes.
- Base editing offers precise single-nucleotide genome modification.
Conclusions:
- CRISPR/Cas9 systems offer diverse 'flavors' for genetic manipulation.
- These systems are instrumental in developing advanced mouse models for cancer research.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

